跳至主要内容
临床试验/NCT02941835
NCT02941835终止不适用

Preoperative Breast Irradiation, the PROBI Trial. A Phase I/II Feasibility Trial

The Netherlands Cancer Institute2 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2018年3月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
4
试验地点
2
主要终点
Postoperative surgical complications

研究概览

简要总结

The PROBI is a phase I/II trial assessing the feasibility of preoperative whole breast irradiation in female patients with low to intermediate risk breast cancer, who undergo breast conserving therapy, including a boost dose of irradiation.

An additional goal of this study is to assess tumor response to radiotherapy, by imaging modalities (PET-CT and MRI) and pathology

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Histologically proven invasive breast carcinoma
  • cT1-2N0 breast cancer
  • female patients ≤ 50 years
  • planned breast conserving surgery
  • ability to undergo irradiation and surgery
  • signed written informed consent

排除标准

  • prior surgery or radiotherapy for the protocol tumor (neoadjuvant chemotherapy or endocrine therapy is allowed)
  • planned oncoplastic reduction mammoplasty
  • extensive calcifications on mammagram (Birads 3,4 or 5)
  • cT3-4 and/or cN1-3 invasive carcinoma
  • distant metastasis

研究组 & 干预措施

radiation

Other

intervention: pre-operative breast irradiation of 21 fx of 2.2Gy and boost 2.66Gy

干预措施: pre-operative irradiation (Radiation)

结局指标

主要结局

Postoperative surgical complications

时间窗: within six weeks after surgery

postoperative complication will be scored by a specific list

次要结局

  • Radiological response(6 weeks post-radiation)
  • Pathological response(at surgery)
  • cosmetic outcome(1,3 and 5 years post-treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验